Unum Therapeutics

Biotech

Bayer's BlueRock promotes CSO to CEO, president roles

Parkinson's disease biotech BlueRock Therapeutics, owned by Bayer, promoted Chief Scientific Officer Seth Ettenberg, Ph.D., to CEO and president.

Kyle LaHucik Jul 26, 2021 11:23am

Close-up of two people shaking hands with other people in the background

Unum's CAR-T tech lands at Czech biotech Sotio in $8.1M deal

Aug 31, 2020 8:30am

FDA Building 2

Days after wielding the ax, Unum hit with clinical hold, again

Mar 10, 2020 7:30am

Prostate Cancer

Unum dumps clinical work, slashes 60% of workforce as CSO walks

Mar 2, 2020 11:11am

Unum Therapeutics

FDA puts Unum T cell therapy trial on hold after adverse events

Jul 3, 2019 10:52am

Nasdaq

Unum IPO hits bottom of range, nets $62M for cancer trials

Mar 29, 2018 9:15am